AI-assisted, human-published
10/18/2024 /Funding Events
Terray Therapeutics Secures $120 Million in Series B Funding for Advancing AI-Driven Drug Development
The funding will propel internal programs into clinical trials and enhance the integrated AI platform, tNova, to revolutionize small molecule therapeutics discovery.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com